Non-Alcoholic Fatty Liver Disease

Fatty liver is a disease where large vacuoles of triglyceride fat accumulated in liver cells via the process of steatosis. i.e. abnormal retention of lipid within a cell. Fatty liver mostly occurred in the high risk group of people such as:


Obese People
Sedentary Life
Alcoholic

Chronic Liver Disease
High Fat Diet
Middle Aged with Hormone Imbalance
SCIENTIFIC RESEARCH

Journal of Life Science (2009): Chromium group confirmed it can raise the antioxidant capacity in liver thus protecting it against cell damages. Besides, it also helps in reducing inflammation and speeding up the recovery of damaged cells. While concurrently regulating blood glucose and fat metabolism, it also reduces the burden of liver by reducing the sugar and fat, thus improving the function of liver.

Journal of Biochemical and Biophysical Research Communications (2010): Chromium supplementation prevented progression of non-alcoholic fatty liver disease (NAFLD) and the beneficial effects were accompanied by reduction of hepatic triglyceride accumulation, elevation of hepatic lipid catabolic enzyme, improvement of glucose and lipid metabolism, suppression of inflammation as well as resolution of oxidative stress. Chromium could serve as a hepatoprotective agent against NAFLD.
 GT&F® attenuates hepatic triglyceride  GT&F® improves liver function